Shares of Nektar Therapeutics (NKTR) have been struggling lately and have lost 11.5% over the past four weeks. However, a hammer chart pattern was formed in its last trading session, which could ...

Nektar Therapeutics Stock Performance NASDAQ:NKTR opened at $0.89 on Friday. Nektar Therapeutics has a 52-week low of $0.48 and a 52-week high of $1.93. The stock has a fifty day moving average of ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders.